knowledge -WSS

knowledge

author：leisure time 2025-09-30 09:56:48 - browse：429

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Pumping milk in bathrooms at health conferences is common

focus

explore

WSS

GSK’s asthma push continues as drug succeeds in Phase 3 trials

To bolster infectious disease surveillance, genomics powerhouses team up

Empower primary care with adequate payments and technology

PBM executives asked to testify by House panel

PBM executives asked to testify by House panel

The effects of a landmark ruling on DNA ownership are becoming clearer

Wikipedia

knowledge

focus

Continuity nursing helped my family in our darkest PICU moments

Welsh Carson private equity firm escapes from FTC antitrust case

Hepatitis C has a cure — but many Americans still lack access to it

Lawmakers grill UnitedHealth CEO on Change cyberattack

Medical leaders decry Supreme Court decision on affirmative action

Mass General, Mayo Clinic look to monetize custom

Novavax promises a turnaround & Lilly roils the obesity market

HHS's proposed rule does nothing to address the climate crisis

DIEP, the 'gold standard' of breast reconstruction, is under threat

Class action alleges UnitedHealth concealed DOJ probe

focus

Immunocompromised patients offer clues on chronic Covid

Warren pushes Witty on UnitedHealth's control over physicians

Microsoft launches AI tool for clinical documentation through Epic

Crowdfunding for medical bills sidesteps core problem, author says

Future doctors need a strong humanities education

Update the Apgar Score to remove skin color

focus

explore

hotspot

focus